2012 - NF Pharma

Report
COMPANY PRESENTATION
Kazakhstan
2012
ABOUT US

We NF Pharma is a pharma division of
Reliable Group Kazakhstan established in
the year 2002. Reliable is mainly into
promotion & marketing of many
multinational brands both in pharma as well
as in FMCG sector. We have our offices in
Moscow, Kiev, Shanghai & Dubai also.
Kazakhstan
2012
ABOUT US

The total turnover of Reliable group is 10
mln. USD, out of that 6 mln. USD is from
Reliable marketing & 4 mln. USD is from NF
Pharma.
We have plan to have a growth of 100% in the
coming financial year.
Kazakhstan
2012
ABOUT US

We have been in the market for the last 6
years and are involved in
import,
distribution
and
marketing
of
pharmaceutical products, having our own
warehouse which meets all the facilities as
per the law of Kazakhstan, we cover all the
cities in Kazakhstan through local
distributors or medical shops and we work
with government organizations directly.
Kazakhstan
2012
ABOUT US

o
o
o
o
We have been working with the following
companies :
PIRAMAL HEALTHCARE
MDF INSTRUMENTS
SANBE PHARMA
DYNAMIC
o
o
o
o
USV LIMITED
AUROCHEM LAB.
GETZ PHARMA
RUSAN PHARMA
Kazakhstan
2012
ABOUT US

o
o
o
o
o
Except that Reliable marketing is working
with many MNC’s, some of which are:
Procter & Gamble
Henkel
Kraft foods
Pepsi Bottlers
Coca Cola Bottlers etc.
Kazakhstan
2012
OUR STRENGTH




Experience in Kazakhstan market for almost
10 years.
Pharma operation experience 6 Years.
Working with leading companies with good
growth.
We are the only company who can provide
the full fledge support to our business
partner from initiation to complete
execution of the projects by helping them
in:
1. Product Selection: We do the total market analysis &
help the companies to select the product for entering into
the market.
2. Registration Control: We take up the total registration
responsibility and help the companies to expedite the
process with having our own regulatory department.
3. Importation: We take care of import, custom clearance
& help the companies for maintaining the proper inventory
in our warehouse.
Kazakhstan
2012
OUR STRENGTH
4. Distribution: We are covering all the major cities all over
the country , working with all the sub distributors.
5. Marketing: We are already marketing some products in
Almaty having a field force of 25 and planning to increase
the marketing team strength to cover all the 14 provinces
of Kazakhstan.


We are passionate about what we do and
we are good at it which translates into a
very positive experience with our partners
resulting in long term relationships.
Therefore we would be the best business
partner for any company who wants to
enter in to the market with complete
professional support .
Kazakhstan
2012
OUR RECENT
ACHEIVEMENT


We have won a tender for Nicholas Piramal
Ltd. for the product Sevoflurane of value
apprx. 1.5 mln. USD. After 10 days of its
registration, against MNC like Abbott. It was
a very difficult project but with our
confidence & correct strategy we have
executed it very well.
We are having our own local retail medical
shops in Almaty which we are planning to
extend to other regions of Kazakhstan.
Kazakhstan
2012
KAZAKHSTAN
COUNTRY PROFILE

Kazakhstan is situated in Central Asia, deep
in the Eurasian continent.

Territory : 2.7 million sq.km. (second largest
among CIS & ninth place in the world.

It is the leader among the CIS countries for
direct investment per capita.
Kazakhstan
2012
KAZAKHSTAN
COUNTRY PROFILE







Total Population : 16.5 million
Population density : 5.5 /sq.km.
Sex ratio
: 0.90/female
Life expectancy
: 67 Years
Literacy
: 100 %
Languages
: Kazakh (official)
Russian
Ethnic groups
: Kazakh, Russian
Turkmen, Uighurs
Uzbek, Tajik
Kazakhstan
2012
KAZAKHSTAN
ECONOMY (MACRO)




Kazakhstan is important to world energy
markets because of its significant oil &
natural gas reserves.
The country could become one of the
world’s largest oil producers & exporters in
the next decade, particularly the Kazakh
sector of Caspian sea could attract between
150-200 bln. USD.
This country has enjoyed impressive
economic growth over the past five years.
Kazakhstan remains one of the most
successful reformers in the CIS, and it has
the strongest banking system in Central Asia
and CIS.

Kazakhstan has become the first country in
the CIS to reach investment grade status.
Kazakhstan
2012
KAZAKHSTAN
ECONOMY(MICRO)

GDP
: US $ 210 Billion

Growth rate
: 5.0%

Per Capita Income : 13484 US $

Unemployment
: 6.9%

Fiscal Year
: Calendar Year

Export
: $ 66.57 bn

Import
: $ 37.53 bn

Main partners : Russia , Germany, China &
France
Kazakhstan
2012
PHARMACEUTICAL
SCENARIO

Volume
: 1290 million USD (2010)
By 2012, the market is expected to be worth
around US$ 1.645 bln,

Growth

Local Production :
10-11% of total volume

Preparations
>7 thousand

Foreign companies : Over 100 (total > 200)

Largest suppliers :
:
:
18% annually
France, Germany,
Russia & USA
Kazakhstan
2012
REGULATORY SCENARIO

Registration is done by MoH (National
center of Expertise on drugs).

Certificate is issued by MoH.

Registration validity : 5 years

Time required : 10-12 months ( we can
expedite the process if dossier is o.k. As per
the CTD requirement.)

Official Fee : 3500 – 5000 USD (depending
on the combination & therapeutic group)

Unofficial fee : 6000 USD ( Includes all the
other expenses like translation , Xerox,
motivational fee on each stage, art works ,
stationaries etc.
Kazakhstan
2012
Kazakhstan
2012

similar documents